TY - JOUR T1 - microRNAs-mediated regulation of insulin signaling in white adipose tissue during aging: Role of caloric restriction. JF - Aging Cell Y1 - 2023 A1 - Corrales, Patricia A1 - Martin-Taboada, Marina A1 - Vivas-García, Yurena A1 - Torres, Lucia A1 - Ramirez-Jimenez, Laura A1 - Lopez, Yamila A1 - Horrillo, Daniel A1 - Vila-Bedmar, Rocio A1 - Barber-Cano, Eloisa A1 - Izquierdo-Lahuerta, Adriana A1 - Peña-Chilet, Maria A1 - Martínez, Carmen A1 - Dopazo, Joaquin A1 - Ros, Manuel A1 - Medina-Gomez, Gema AB -

Caloric restriction is a non-pharmacological intervention known to ameliorate the metabolic defects associated with aging, including insulin resistance. The levels of miRNA expression may represent a predictive tool for aging-related alterations. In order to investigate the role of miRNAs underlying insulin resistance in adipose tissue during the early stages of aging, 3- and 12-month-old male animals fed ad libitum, and 12-month-old male animals fed with a 20% caloric restricted diet were used. In this work we demonstrate that specific miRNAs may contribute to the impaired insulin-stimulated glucose metabolism specifically in the subcutaneous white adipose tissue, through the regulation of target genes implicated in the insulin signaling cascade. Moreover, the expression of these miRNAs is modified by caloric restriction in middle-aged animals, in accordance with the improvement of the metabolic state. Overall, our work demonstrates that alterations in posttranscriptional gene expression because of miRNAs dysregulation might represent an endogenous mechanism by which insulin response in the subcutaneous fat depot is already affected at middle age. Importantly, caloric restriction could prevent this modulation, demonstrating that certain miRNAs could constitute potential biomarkers of age-related metabolic alterations.

ER - TY - JOUR T1 - Incidence and Prevalence of Children's Diffuse Lung Disease in Spain. JF - Arch Bronconeumol Y1 - 2022 A1 - Torrent-Vernetta, Alba A1 - Gaboli, Mirella A1 - Castillo-Corullón, Silvia A1 - Mondéjar-López, Pedro A1 - Sanz Santiago, Verónica A1 - Costa-Colomer, Jordi A1 - Osona, Borja A1 - Torres-Borrego, Javier A1 - de la Serna-Blázquez, Olga A1 - Bellón Alonso, Sara A1 - Caro Aguilera, Pilar A1 - Gimeno-Díaz de Atauri, Álvaro A1 - Valenzuela Soria, Alfredo A1 - Ayats, Roser A1 - Martin de Vicente, Carlos A1 - Velasco González, Valle A1 - Moure González, José Domingo A1 - Canino Calderín, Elisa María A1 - Pastor-Vivero, María Dolores A1 - Villar Álvarez, María Ángeles A1 - Rovira-Amigo, Sandra A1 - Iglesias Serrano, Ignacio A1 - Díez Izquierdo, Ana A1 - de Mir Messa, Inés A1 - Gartner, Silvia A1 - Navarro, Alexandra A1 - Baz-Redón, Noelia A1 - Carmona, Rosario A1 - Camats-Tarruella, Núria A1 - Fernández-Cancio, Mónica A1 - Rapp, Christina A1 - Dopazo, Joaquin A1 - Griese, Matthias A1 - Moreno-Galdó, Antonio AB -

BACKGROUND: Children's diffuse lung disease, also known as children's Interstitial Lung Diseases (chILD), are a heterogeneous group of rare diseases with relevant morbidity and mortality, which diagnosis and classification are very complex. Epidemiological data are scarce. The aim of this study was to analyse incidence and prevalence of chILD in Spain.

METHODS: Multicentre observational prospective study in patients from 0 to 18 years of age with chILD to analyse its incidence and prevalence in Spain, based on data reported in 2018 and 2019.

RESULTS: A total of 381 cases with chILD were notified from 51 paediatric pulmonology units all over Spain, covering the 91.7% of the paediatric population. The average incidence of chILD was 8.18 (CI 95% 6.28-10.48) new cases/million of children per year. The average prevalence of chILD was 46.53 (CI 95% 41.81-51.62) cases/million of children. The age group with the highest prevalence were children under 1 year of age. Different types of disorders were seen in children 2-18 years of age compared with children 0-2 years of age. Most frequent cases were: primary pulmonary interstitial glycogenosis in neonates (17/65), neuroendocrine cell hyperplasia of infancy in infants from 1 to 12 months (44/144), idiopathic pulmonary haemosiderosis in children from 1 to 5 years old (13/74), hypersensitivity pneumonitis in children from 5 to 10 years old (9/51), and scleroderma in older than 10 years old (8/47).

CONCLUSIONS: We found a higher incidence and prevalence of chILD than previously described probably due to greater understanding and increased clinician awareness of these rare diseases.

VL - 58 IS - 1 ER - TY - JOUR T1 - COVID19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms. JF - Mol Syst Biol Y1 - 2021 A1 - Ostaszewski, Marek A1 - Niarakis, Anna A1 - Mazein, Alexander A1 - Kuperstein, Inna A1 - Phair, Robert A1 - Orta-Resendiz, Aurelio A1 - Singh, Vidisha A1 - Aghamiri, Sara Sadat A1 - Acencio, Marcio Luis A1 - Glaab, Enrico A1 - Ruepp, Andreas A1 - Fobo, Gisela A1 - Montrone, Corinna A1 - Brauner, Barbara A1 - Frishman, Goar A1 - Monraz Gómez, Luis Cristóbal A1 - Somers, Julia A1 - Hoch, Matti A1 - Kumar Gupta, Shailendra A1 - Scheel, Julia A1 - Borlinghaus, Hanna A1 - Czauderna, Tobias A1 - Schreiber, Falk A1 - Montagud, Arnau A1 - Ponce de Leon, Miguel A1 - Funahashi, Akira A1 - Hiki, Yusuke A1 - Hiroi, Noriko A1 - Yamada, Takahiro G A1 - Dräger, Andreas A1 - Renz, Alina A1 - Naveez, Muhammad A1 - Bocskei, Zsolt A1 - Messina, Francesco A1 - Börnigen, Daniela A1 - Fergusson, Liam A1 - Conti, Marta A1 - Rameil, Marius A1 - Nakonecnij, Vanessa A1 - Vanhoefer, Jakob A1 - Schmiester, Leonard A1 - Wang, Muying A1 - Ackerman, Emily E A1 - Shoemaker, Jason E A1 - Zucker, Jeremy A1 - Oxford, Kristie A1 - Teuton, Jeremy A1 - Kocakaya, Ebru A1 - Summak, Gökçe Yağmur A1 - Hanspers, Kristina A1 - Kutmon, Martina A1 - Coort, Susan A1 - Eijssen, Lars A1 - Ehrhart, Friederike A1 - Rex, Devasahayam Arokia Balaya A1 - Slenter, Denise A1 - Martens, Marvin A1 - Pham, Nhung A1 - Haw, Robin A1 - Jassal, Bijay A1 - Matthews, Lisa A1 - Orlic-Milacic, Marija A1 - Senff Ribeiro, Andrea A1 - Rothfels, Karen A1 - Shamovsky, Veronica A1 - Stephan, Ralf A1 - Sevilla, Cristoffer A1 - Varusai, Thawfeek A1 - Ravel, Jean-Marie A1 - Fraser, Rupsha A1 - Ortseifen, Vera A1 - Marchesi, Silvia A1 - Gawron, Piotr A1 - Smula, Ewa A1 - Heirendt, Laurent A1 - Satagopam, Venkata A1 - Wu, Guanming A1 - Riutta, Anders A1 - Golebiewski, Martin A1 - Owen, Stuart A1 - Goble, Carole A1 - Hu, Xiaoming A1 - Overall, Rupert W A1 - Maier, Dieter A1 - Bauch, Angela A1 - Gyori, Benjamin M A1 - Bachman, John A A1 - Vega, Carlos A1 - Grouès, Valentin A1 - Vazquez, Miguel A1 - Porras, Pablo A1 - Licata, Luana A1 - Iannuccelli, Marta A1 - Sacco, Francesca A1 - Nesterova, Anastasia A1 - Yuryev, Anton A1 - de Waard, Anita A1 - Turei, Denes A1 - Luna, Augustin A1 - Babur, Ozgun A1 - Soliman, Sylvain A1 - Valdeolivas, Alberto A1 - Esteban-Medina, Marina A1 - Peña-Chilet, Maria A1 - Rian, Kinza A1 - Helikar, Tomáš A1 - Puniya, Bhanwar Lal A1 - Modos, Dezso A1 - Treveil, Agatha A1 - Olbei, Marton A1 - De Meulder, Bertrand A1 - Ballereau, Stephane A1 - Dugourd, Aurélien A1 - Naldi, Aurélien A1 - Noël, Vincent A1 - Calzone, Laurence A1 - Sander, Chris A1 - Demir, Emek A1 - Korcsmaros, Tamas A1 - Freeman, Tom C A1 - Augé, Franck A1 - Beckmann, Jacques S A1 - Hasenauer, Jan A1 - Wolkenhauer, Olaf A1 - Wilighagen, Egon L A1 - Pico, Alexander R A1 - Evelo, Chris T A1 - Gillespie, Marc E A1 - Stein, Lincoln D A1 - Hermjakob, Henning A1 - D'Eustachio, Peter A1 - Saez-Rodriguez, Julio A1 - Dopazo, Joaquin A1 - Valencia, Alfonso A1 - Kitano, Hiroaki A1 - Barillot, Emmanuel A1 - Auffray, Charles A1 - Balling, Rudi A1 - Schneider, Reinhard KW - Antiviral Agents KW - Computational Biology KW - Computer Graphics KW - COVID-19 KW - Cytokines KW - Data Mining KW - Databases, Factual KW - Gene Expression Regulation KW - Host Microbial Interactions KW - Humans KW - Immunity, Cellular KW - Immunity, Humoral KW - Immunity, Innate KW - Lymphocytes KW - Metabolic Networks and Pathways KW - Myeloid Cells KW - Protein Interaction Mapping KW - SARS-CoV-2 KW - Signal Transduction KW - Software KW - Transcription Factors KW - Viral Proteins AB -

We need to effectively combine the knowledge from surging literature with complex datasets to propose mechanistic models of SARS-CoV-2 infection, improving data interpretation and predicting key targets of intervention. Here, we describe a large-scale community effort to build an open access, interoperable and computable repository of COVID-19 molecular mechanisms. The COVID-19 Disease Map (C19DMap) is a graphical, interactive representation of disease-relevant molecular mechanisms linking many knowledge sources. Notably, it is a computational resource for graph-based analyses and disease modelling. To this end, we established a framework of tools, platforms and guidelines necessary for a multifaceted community of biocurators, domain experts, bioinformaticians and computational biologists. The diagrams of the C19DMap, curated from the literature, are integrated with relevant interaction and text mining databases. We demonstrate the application of network analysis and modelling approaches by concrete examples to highlight new testable hypotheses. This framework helps to find signatures of SARS-CoV-2 predisposition, treatment response or prioritisation of drug candidates. Such an approach may help deal with new waves of COVID-19 or similar pandemics in the long-term perspective.

VL - 17 IS - 10 U1 - https://www.ncbi.nlm.nih.gov/pubmed/34664389?dopt=Abstract ER - TY - JOUR T1 - De novo small deletion affecting transcription start site of short isoform of AUTS2 gene in a patient with syndromic neurodevelopmental defects. JF - Am J Med Genet A Y1 - 2021 A1 - Martinez-Delgado, Beatriz A1 - Lopez-Martin, Estrella A1 - Lara-Herguedas, Julián A1 - Monzon, Sara A1 - Cuesta, Isabel A1 - Juliá, Miguel A1 - Aquino, Virginia A1 - Rodriguez-Martin, Carlos A1 - Damian, Alejandra A1 - Gonzalo, Irene A1 - Gomez-Mariano, Gema A1 - Baladron, Beatriz A1 - Cazorla, Rosario A1 - Iglesias, Gema A1 - Roman, Enriqueta A1 - Ros, Purificacion A1 - Tutor, Pablo A1 - Mellor, Susana A1 - Jimenez, Carlos A1 - Cabrejas, Maria Jose A1 - Gonzalez-Vioque, Emiliano A1 - Alonso, Javier A1 - Bermejo-Sánchez, Eva A1 - Posada, Manuel KW - Child, Preschool KW - Cytoskeletal Proteins KW - Dwarfism KW - Exons KW - Gene Expression Regulation KW - Genetic Association Studies KW - Humans KW - Male KW - Neurodevelopmental Disorders KW - Protein Isoforms KW - RNA, Messenger KW - Sequence Deletion KW - Syndrome KW - Transcription Factors KW - Transcription Initiation Site KW - Transcription, Genetic AB -

Disruption of the autism susceptibility candidate 2 (AUTS2) gene through genomic rearrangements, copy number variations (CNVs), and intragenic deletions and mutations, has been recurrently involved in syndromic forms of developmental delay and intellectual disability, known as AUTS2 syndrome. The AUTS2 gene plays an important role in regulation of neuronal migration, and when altered, associates with a variable phenotype from severely to mildly affected patients. The more severe phenotypes significantly correlate with the presence of defects affecting the C-terminus part of the gene. This article reports a new patient with a syndromic neurodevelopmental disorder, who presents a deletion of 30 nucleotides in the exon 9 of the AUTS2 gene. Importantly, this deletion includes the transcription start site for the AUTS2 short transcript isoform, which has an important role in brain development. Gene expression analysis of AUTS2 full-length and short isoforms revealed that the deletion found in this patient causes a remarkable reduction in the expression level, not only of the short isoform, but also of the full AUTS2 transcripts. This report adds more evidence for the role of mutated AUTS2 short transcripts in the development of a severe phenotype in the AUTS2 syndrome.

VL - 185 IS - 3 ER - TY - JOUR T1 - A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin. JF - Mol Oncol Y1 - 2021 A1 - Moura, David S A1 - Peña-Chilet, Maria A1 - Cordero Varela, Juan Antonio A1 - Alvarez-Alegret, Ramiro A1 - Agra-Pujol, Carolina A1 - Izquierdo, Francisco A1 - Ramos, Rafael A1 - Ortega-Medina, Luis A1 - Martin-Davila, Francisco A1 - Castilla-Ramirez, Carolina A1 - Hernandez-Leon, Carmen Nieves A1 - Romagosa, Cleofe A1 - Vaz Salgado, Maria Angeles A1 - Lavernia, Javier A1 - Bagué, Silvia A1 - Mayodormo-Aranda, Empar A1 - Vicioso, Luis A1 - Hernández Barceló, Jose Emilio A1 - Rubio-Casadevall, Jordi A1 - de Juan, Ana A1 - Fiaño-Valverde, Maria Concepcion A1 - Hindi, Nadia A1 - Lopez-Alvarez, Maria A1 - Lacerenza, Serena A1 - Dopazo, Joaquin A1 - Gutierrez, Antonio A1 - Alvarez, Rosa A1 - Valverde, Claudia A1 - Martinez-Trufero, Javier A1 - Martin-Broto, Javier AB -

Predictive biomarkers of trabectedin represent an unmet need in advanced soft-tissue sarcomas (STS). DNA damage repair (DDR) genes, involved in homologous recombination or nucleotide excision repair, had been previously described as biomarkers of trabectedin resistance or sensitivity, respectively. The majority of these studies only focused on specific factors (ERCC1, ERCC5, and BRCA1) and did not evaluate several other DDR-related genes that could have a relevant role for trabectedin efficacy. In this retrospective translational study, 118 genes involved in DDR were evaluated to determine, by transcriptomics, a predictive gene signature of trabectedin efficacy. A six-gene predictive signature of trabectedin efficacy was built in a series of 139 tumor samples from patients with advanced STS. Patients in the high-risk gene signature group showed a significantly worse progression-free survival compared with patients in the low-risk group (2.1 vs 6.0 months, respectively). Differential gene expression analysis defined new potential predictive biomarkers of trabectedin sensitivity (PARP3 and CCNH) or resistance (DNAJB11 and PARP1). Our study identified a new gene signature that significantly predicts patients with higher probability to respond to treatment with trabectedin. Targeting some genes of this signature emerges as a potential strategy to enhance trabectedin efficacy.

VL - 15 IS - 12 U1 - https://www.ncbi.nlm.nih.gov/pubmed/33983674?dopt=Abstract ER - TY - JOUR T1 - The NCI Genomic Data Commons JF - Nature Genetics Y1 - 2021 A1 - Heath, Allison P. A1 - Ferretti, Vincent A1 - Agrawal, Stuti A1 - An, Maksim A1 - Angelakos, James C. A1 - Arya, Renuka A1 - Bajari, Rosita A1 - Baqar, Bilal A1 - Barnowski, Justin H. B. A1 - Burt, Jeffrey A1 - Catton, Ann A1 - Chan, Brandon F. A1 - Chu, Fay A1 - Cullion, Kim A1 - Davidsen, Tanja A1 - Do, Phuong-My A1 - Dompierre, Christian A1 - Ferguson, Martin L. A1 - Fitzsimons, Michael S. A1 - Ford, Michael A1 - Fukuma, Miyuki A1 - Gaheen, Sharon A1 - Ganji, Gajanan L. A1 - Garcia, Tzintzuni I. A1 - George, Sameera S. A1 - Gerhard, Daniela S. A1 - Gerthoffert, Francois A1 - Gomez, Fauzi A1 - Han, Kang A1 - Hernandez, Kyle M. A1 - Issac, Biju A1 - Jackson, Richard A1 - Jensen, Mark A. A1 - Joshi, Sid A1 - Kadam, Ajinkya A1 - Khurana, Aishmit A1 - Kim, Kyle M. J. A1 - Kraft, Victoria E. A1 - Li, Shenglai A1 - Lichtenberg, Tara M. A1 - Lodato, Janice A1 - Lolla, Laxmi A1 - Martinov, Plamen A1 - Mazzone, Jeffrey A. A1 - Miller, Daniel P. A1 - Miller, Ian A1 - Miller, Joshua S. A1 - Miyauchi, Koji A1 - Murphy, Mark W. A1 - Nullet, Thomas A1 - Ogwara, Rowland O. A1 - Ortuño, Francisco M. A1 - Pedrosa, Jesús A1 - Pham, Phuong L. A1 - Popov, Maxim Y. A1 - Porter, James J. A1 - Powell, Raymond A1 - Rademacher, Karl A1 - Reid, Colin P. A1 - Rich, Samantha A1 - Rogel, Bessie A1 - Sahni, Himanso A1 - Savage, Jeremiah H. A1 - Schmitt, Kyle A. A1 - Simmons, Trevar J. A1 - Sislow, Joseph A1 - Spring, Jonathan A1 - Stein, Lincoln A1 - Sullivan, Sean A1 - Tang, Yajing A1 - Thiagarajan, Mathangi A1 - Troyer, Heather D. A1 - Wang, Chang A1 - Wang, Zhining A1 - West, Bedford L. A1 - Wilmer, Alex A1 - Wilson, Shane A1 - Wu, Kaman A1 - Wysocki, William P. A1 - Xiang, Linda A1 - Yamada, Joseph T. A1 - Yang, Liming A1 - Yu, Christine A1 - Yung, Christina K. A1 - Zenklusen, Jean Claude A1 - Zhang, Junjun A1 - Zhang, Zhenyu A1 - Zhao, Yuanheng A1 - Zubair, Ariz A1 - Staudt, Louis M. A1 - Grossman, Robert L. UR - http://www.nature.com/articles/s41588-021-00791-5 JO - Nat Genet ER - TY - JOUR T1 - Transparency and reproducibility in artificial intelligence. JF - Nature Y1 - 2020 A1 - Haibe-Kains, Benjamin A1 - Adam, George Alexandru A1 - Hosny, Ahmed A1 - Khodakarami, Farnoosh A1 - Waldron, Levi A1 - Wang, Bo A1 - McIntosh, Chris A1 - Goldenberg, Anna A1 - Kundaje, Anshul A1 - Greene, Casey S A1 - Broderick, Tamara A1 - Hoffman, Michael M A1 - Leek, Jeffrey T A1 - Korthauer, Keegan A1 - Huber, Wolfgang A1 - Brazma, Alvis A1 - Pineau, Joelle A1 - Tibshirani, Robert A1 - Hastie, Trevor A1 - Ioannidis, John P A A1 - Quackenbush, John A1 - Aerts, Hugo J W L KW - Algorithms KW - Artificial Intelligence KW - Reproducibility of Results VL - 586 IS - 7829 U1 - https://www.ncbi.nlm.nih.gov/pubmed/33057217?dopt=Abstract ER - TY - JOUR T1 - Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial. JF - Lancet Oncol Y1 - 2019 A1 - Martin-Broto, Javier A1 - Stacchiotti, Silvia A1 - Lopez-Pousa, Antonio A1 - Redondo, Andres A1 - Bernabeu, Daniel A1 - de Alava, Enrique A1 - Casali, Paolo G A1 - Italiano, Antoine A1 - Gutierrez, Antonio A1 - Moura, David S A1 - Peña-Chilet, Maria A1 - Diaz-Martin, Juan A1 - Biscuola, Michele A1 - Taron, Miguel A1 - Collini, Paola A1 - Ranchere-Vince, Dominique A1 - Garcia Del Muro, Xavier A1 - Grignani, Giovanni A1 - Dumont, Sarah A1 - Martinez-Trufero, Javier A1 - Palmerini, Emanuela A1 - Hindi, Nadia A1 - Sebio, Ana A1 - Dopazo, Joaquin A1 - Dei Tos, Angelo Paolo A1 - LeCesne, Axel A1 - Blay, Jean-Yves A1 - Cruz, Josefina KW - Adult KW - Aged KW - Angiogenesis Inhibitors KW - Antineoplastic Agents KW - Female KW - Humans KW - Indazoles KW - Male KW - Middle Aged KW - Multivariate Analysis KW - Pyrimidines KW - Response Evaluation Criteria in Solid Tumors KW - Soft Tissue Neoplasms KW - Solitary Fibrous Tumors KW - Sulfonamides KW - Survival Analysis AB -

BACKGROUND: A solitary fibrous tumour is a rare soft-tissue tumour with three clinicopathological variants: typical, malignant, and dedifferentiated. Preclinical experiments and retrospective studies have shown different sensitivities of solitary fibrous tumour to chemotherapy and antiangiogenics. We therefore designed a trial to assess the activity of pazopanib in a cohort of patients with malignant or dedifferentiated solitary fibrous tumour. The clinical and translational results are presented here.

METHODS: In this single-arm, phase 2 trial, adult patients (aged ≥ 18 years) with histologically confirmed metastatic or unresectable malignant or dedifferentiated solitary fibrous tumour at any location, who had progressed (by RECIST and Choi criteria) in the previous 6 months and had an ECOG performance status of 0-2, were enrolled at 16 third-level hospitals with expertise in sarcoma care in Spain, Italy, and France. Patients received pazopanib 800 mg once daily, taken orally without food, at least 1 h before or 2 h after a meal, until progression or intolerance. The primary endpoint of the study was overall response measured by Choi criteria in the subset of the intention-to-treat population (patients who received at least 1 month of treatment with at least one radiological assessment). All patients who received at least one dose of the study drug were included in the safety analyses. This study is registered with ClinicalTrials.gov, number NCT02066285, and with the European Clinical Trials Database, EudraCT number 2013-005456-15.

FINDINGS: From June 26, 2014, to Nov 24, 2016, of 40 patients assessed, 36 were enrolled (34 with malignant solitary fibrous tumour and two with dedifferentiated solitary fibrous tumour). Median follow-up was 27 months (IQR 16-31). Based on central radiology review, 18 (51%) of 35 evaluable patients had partial responses, nine (26%) had stable disease, and eight (23%) had progressive disease according to Choi criteria. Further enrolment of patients with dedifferentiated solitary fibrous tumour was stopped after detection of early and fast progressions in a planned interim analysis. 51% (95% CI 34-69) of 35 patients achieved an overall response according to Choi criteria. Ten (29%) of 35 patients died. There were no deaths related to adverse events and the most frequent grade 3 or higher adverse events were hypertension (11 [31%] of 36 patients), neutropenia (four [11%]), increased concentrations of alanine aminotransferase (four [11%]), and increased concentrations of bilirubin (three [8%]).

INTERPRETATION: To our knowledge, this is the first trial of pazopanib for treatment of malignant solitary fibrous tumour showing activity in this patient group. The manageable toxicity profile and the activity shown by pazopanib suggests that this drug could be an option for systemic treatment of advanced malignant solitary fibrous tumour, and provides a benchmark for future trials.

FUNDING: Spanish Group for Research on Sarcomas (GEIS), Italian Sarcoma Group (ISG), French Sarcoma Group (FSG), GlaxoSmithKline, and Novartis.

VL - 20 IS - 1 U1 - https://www.ncbi.nlm.nih.gov/pubmed/30578023?dopt=Abstract ER - TY - JOUR T1 - Genomics of the origin and evolution of Citrus. JF - Nature Y1 - 2018 A1 - Wu, Guohong Albert A1 - Terol, Javier A1 - Ibañez, Victoria A1 - López-García, Antonio A1 - Pérez-Román, Estela A1 - Borredá, Carles A1 - Domingo, Concha A1 - Tadeo, Francisco R A1 - Carbonell-Caballero, José A1 - Alonso, Roberto A1 - Curk, Franck A1 - Du, Dongliang A1 - Ollitrault, Patrick A1 - Roose, Mikeal L A1 - Dopazo, Joaquin A1 - Gmitter, Frederick G A1 - Rokhsar, Daniel S A1 - Talon, Manuel KW - Asia, Southeastern KW - Biodiversity KW - citrus KW - Crop Production KW - Evolution, Molecular KW - Genetic Speciation KW - Genome, Plant KW - Genomics KW - Haplotypes KW - Heterozygote KW - History, Ancient KW - Human Migration KW - Hybridization, Genetic KW - Phylogeny AB -

The genus Citrus, comprising some of the most widely cultivated fruit crops worldwide, includes an uncertain number of species. Here we describe ten natural citrus species, using genomic, phylogenetic and biogeographic analyses of 60 accessions representing diverse citrus germ plasms, and propose that citrus diversified during the late Miocene epoch through a rapid southeast Asian radiation that correlates with a marked weakening of the monsoons. A second radiation enabled by migration across the Wallace line gave rise to the Australian limes in the early Pliocene epoch. Further identification and analyses of hybrids and admixed genomes provides insights into the genealogy of major commercial cultivars of citrus. Among mandarins and sweet orange, we find an extensive network of relatedness that illuminates the domestication of these groups. Widespread pummelo admixture among these mandarins and its correlation with fruit size and acidity suggests a plausible role of pummelo introgression in the selection of palatable mandarins. This work provides a new evolutionary framework for the genus Citrus.

VL - 554 IS - 7692 U1 - https://www.ncbi.nlm.nih.gov/pubmed/29414943?dopt=Abstract ER - TY - JOUR T1 - The modular network structure of the mutational landscape of Acute Myeloid Leukemia. JF - PLoS One Y1 - 2018 A1 - Ibáñez, Mariam A1 - Carbonell-Caballero, José A1 - Such, Esperanza A1 - García-Alonso, Luz A1 - Liquori, Alessandro A1 - López-Pavía, María A1 - LLop, Marta A1 - Alonso, Carmen A1 - Barragán, Eva A1 - Gómez-Seguí, Inés A1 - Neef, Alexander A1 - Hervás, David A1 - Montesinos, Pau A1 - Sanz, Guillermo A1 - Sanz, Miguel Angel A1 - Dopazo, Joaquin A1 - Cervera, José KW - Adult KW - Aged KW - Cytodiagnosis KW - Female KW - Gene Regulatory Networks KW - Genetic Association Studies KW - Genetic Heterogeneity KW - Humans KW - Karyotype KW - Leukemia, Myeloid, Acute KW - Male KW - Middle Aged KW - mutation KW - Neoplasm Proteins KW - Nucleophosmin KW - Prognosis KW - whole exome sequencing AB -

Acute myeloid leukemia (AML) is associated with the sequential accumulation of acquired genetic alterations. Although at diagnosis cytogenetic alterations are frequent in AML, roughly 50% of patients present an apparently normal karyotype (NK), leading to a highly heterogeneous prognosis. Due to this significant heterogeneity, it has been suggested that different molecular mechanisms may trigger the disease with diverse prognostic implications. We performed whole-exome sequencing (WES) of tumor-normal matched samples of de novo AML-NK patients lacking mutations in NPM1, CEBPA or FLT3-ITD to identify new gene mutations with potential prognostic and therapeutic relevance to patients with AML. Novel candidate-genes, together with others previously described, were targeted resequenced in an independent cohort of 100 de novo AML patients classified in the cytogenetic intermediate-risk (IR) category. A mean of 4.89 mutations per sample were detected in 73 genes, 35 of which were mutated in more than one patient. After a network enrichment analysis, we defined a single in silico model and established a set of seed-genes that may trigger leukemogenesis in patients with normal karyotype. The high heterogeneity of gene mutations observed in AML patients suggested that a specific alteration could not be as essential as the interaction of deregulated pathways.

VL - 13 IS - 10 U1 - https://www.ncbi.nlm.nih.gov/pubmed/30303964?dopt=Abstract ER - TY - JOUR T1 - The Mutational Landscape of Acute Promyelocytic Leukemia Reveals an Interacting Network of Co-Occurrences and Recurrent Mutations. JF - PLoS One Y1 - 2016 A1 - Ibáñez, Mariam A1 - Carbonell-Caballero, José A1 - García-Alonso, Luz A1 - Such, Esperanza A1 - Jiménez-Almazán, Jorge A1 - Vidal, Enrique A1 - Barragán, Eva A1 - López-Pavía, María A1 - LLop, Marta A1 - Martín, Iván A1 - Gómez-Seguí, Inés A1 - Montesinos, Pau A1 - Sanz, Miguel A A1 - Dopazo, Joaquin A1 - Cervera, José KW - Exome KW - Gene Regulatory Networks KW - Genome, Human KW - Humans KW - INDEL Mutation KW - Leukemia, Promyelocytic, Acute KW - mutation KW - Mutation Rate KW - Polymorphism, Single Nucleotide KW - Reproducibility of Results AB -

Preliminary Acute Promyelocytic Leukemia (APL) whole exome sequencing (WES) studies have identified a huge number of somatic mutations affecting more than a hundred different genes mainly in a non-recurrent manner, suggesting that APL is a heterogeneous disease with secondary relevant changes not yet defined. To extend our knowledge of subtle genetic alterations involved in APL that might cooperate with PML/RARA in the leukemogenic process, we performed a comprehensive analysis of somatic mutations in APL combining WES with sequencing of a custom panel of targeted genes by next-generation sequencing. To select a reduced subset of high confidence candidate driver genes, further in silico analysis were carried out. After prioritization and network analysis we found recurrent deleterious mutations in 8 individual genes (STAG2, U2AF1, SMC1A, USP9X, IKZF1, LYN, MYCBP2 and PTPN11) with a strong potential of being involved in APL pathogenesis. Our network analysis of multiple mutations provides a reliable approach to prioritize genes for additional analysis, improving our knowledge of the leukemogenesis interactome. Additionally, we have defined a functional module in the interactome of APL. The hypothesis is that the number, or the specific combinations, of mutations harbored in each patient might not be as important as the disturbance caused in biological key functions, triggered by several not necessarily recurrent mutations.

VL - 11 IS - 2 U1 - https://www.ncbi.nlm.nih.gov/pubmed/26886259?dopt=Abstract ER - TY - JOUR T1 - Differential Features Between Chronic Skin Inflammatory Diseases Revealed in Skin-Humanized Psoriasis and Atopic Dermatitis Mouse Models. JF - J Invest Dermatol Y1 - 2015 A1 - Carretero, M A1 - Guerrero-Aspizua, S A1 - Illera, N A1 - Galvez, V A1 - Navarro, M A1 - García-García, F A1 - Dopazo, J A1 - Jorcano, J L A1 - Larcher, F A1 - Del Rio, M AB -

Psoriasis (PS) and atopic dermatitis (AD) are chronic and relapsing inflammatory diseases of the skin affecting a large number of patients worldwide. Psoriasis is characterized by a Th1/Th17 immunological response whereas acute AD lesions exhibit Th2-dominant inflammation. Current single gene and signaling pathways-based models of inflammatory skin diseases are incomplete. Previous work allowed us to model psoriasis in skin-humanized mice through proper combinations of inflammatory cell components and disruption of barrier function. Herein we describe and characterize an animal model for AD using similar bioengineered-based approaches, by intradermal injection of human Th2 lymphocytes in regenerated human skin after partial removal of stratum corneum. In the present work we have extensively compared this model with the previous and an improved version of the PS model, in which Th17/Th1 lymphocytes replace exogenous cytokines. Comparative expression analyses revealed marked differences in specific epidermal proliferation and differentiation markers and immune-related molecules including antimicrobial peptides. Likewise, the composition of the dermal inflammatory infiltrate presented important differences. Availability of accurate and reliable animal models for these diseases will contribute to the understanding of the pathogenesis and provide valuable tools for drug development and testing.Journal of Investigative Dermatology accepted article preview online, 23 September 2015. doi:10.1038/jid.2015.362.

U1 - https://www.ncbi.nlm.nih.gov/pubmed/26398345?dopt=Abstract ER - TY - JOUR T1 - Involvement of a citrus meiotic recombination TTC-repeat motif in the formation of gross deletions generated by ionizing radiation and MULE activation. JF - BMC genomics Y1 - 2015 A1 - Terol, Javier A1 - Ibañez, Victoria A1 - Carbonell, José A1 - Alonso, Roberto A1 - Estornell, Leandro H A1 - Licciardello, Concetta A1 - Gut, Ivo G A1 - Joaquín Dopazo A1 - Talon, Manuel AB - BACKGROUND: Transposable-element mediated chromosomal rearrangements require the involvement of two transposons and two double-strand breaks (DSB) located in close proximity. In radiobiology, DSB proximity is also a major factor contributing to rearrangements. However, the whole issue of DSB proximity remains virtually unexplored. RESULTS: Based on DNA sequencing analysis we show that the genomes of 2 derived mutations, Arrufatina (sport) and Nero (irradiation), share a similar 2 Mb deletion of chromosome 3. A 7 kb Mutator-like element found in Clemenules was present in Arrufatina in inverted orientation flanking the 5’ end of the deletion. The Arrufatina Mule displayed "dissimilar" 9-bp target site duplications separated by 2 Mb. Fine-scale single nucleotide variant analyses of the deleted fragments identified a TTC-repeat sequence motif located in the center of the deletion responsible of a meiotic crossover detected in the citrus reference genome. CONCLUSIONS: Taken together, this information is compatible with the proposal that in both mutants, the TTC-repeat motif formed a triplex DNA structure generating a loop that brought in close proximity the originally distinct reactive ends. In Arrufatina, the loop brought the Mule ends nearby the 2 distinct insertion target sites and the inverted insertion of the transposable element between these target sites provoked the release of the in-between fragment. This proposal requires the involvement of a unique transposon and sheds light on the unresolved question of how two distinct sites become located in close proximity. These observations confer a crucial role to the TTC-repeats in fundamental plant processes as meiotic recombination and chromosomal rearrangements. VL - 16 UR - http://www.biomedcentral.com/1471-2164/16/69 ER - TY - JOUR T1 - Involvement of a citrus meiotic recombination TTC-repeat motif in the formation of gross deletions generated by ionizing radiation and MULE activation JF - BMC Genomics Y1 - 2015 A1 - Terol, Javier A1 - Ibañez, Victoria A1 - Carbonell, José A1 - Alonso, Roberto A1 - Estornell, Leandro H. A1 - Licciardello, Concetta A1 - Gut, Ivo G. A1 - Dopazo, Joaquin A1 - Talon, Manuel AB - Transposable-element mediated chromosomal rearrangements require the involvement of two transposons and two double-strand breaks (DSB) located in close proximity. In radiobiology, DSB proximity is also a major factor contributing to rearrangements. However, the whole issue of DSB proximity remains virtually unexplored. VL - 16 UR - https://doi.org/10.1186/s12864-015-1280-3 ER - TY - JOUR T1 - A phylogenetic analysis of 34 chloroplast genomes elucidates the relationships between wild and domestic species within the genus Citrus. JF - Molecular biology and evolution Y1 - 2015 A1 - Carbonell-Caballero, José A1 - Alonso, Roberto A1 - Ibañez, Victoria A1 - Terol, Javier A1 - Talon, Manuel A1 - Dopazo, Joaquin KW - chloroplast KW - citrus KW - Phylogeny KW - WGS AB - Citrus genus includes some of the most important cultivated fruit trees worldwide. Despite being extensively studied because of its commercial relevance, the origin of cultivated citrus species and the history of its domestication still remain an open question. Here we present a phylogenetic analysis of the chloroplast genomes of 34 citrus genotypes which constitutes the most comprehensive and detailed study to date on the evolution and variability of the genus Citrus. A statistical model was used to estimate divergence times between the major citrus groups. Additionally, a complete map of the variability across the genome of different citrus species was produced, including single nucleotide variants, heteroplasmic positions, indels and large structural variants. The distribution of all these variants provided further independent support to the phylogeny obtained. An unexpected finding was the high level of heteroplasmy found in several of the analysed genomes. The use of the complete chloroplast DNA not only paves the way for a better understanding of the phylogenetic relationships within the Citrus genus, but also provides original insights into other elusive evolutionary processes such as chloroplast inheritance, heteroplasmy and gene selection. VL - 32 UR - http://mbe.oxfordjournals.org/content/early/2015/04/27/molbev.msv082.full ER - TY - JOUR T1 - The Activation of the Sox2 RR2 Pluripotency Transcriptional Reporter in Human Breast Cancer Cell Lines is Dynamic and Labels Cells with Higher Tumorigenic Potential. JF - Front Oncol Y1 - 2014 A1 - Iglesias, Juan Manuel A1 - Leis, Olatz A1 - Pérez Ruiz, Estíbaliz A1 - Gumuzio Barrie, Juan A1 - Garcia-Garcia, Francisco A1 - Aduriz, Ariane A1 - Beloqui, Izaskun A1 - Hernandez-Garcia, Susana A1 - Lopez-Mato, Maria Paz A1 - Dopazo, Joaquin A1 - Pandiella, Atanasio A1 - Menendez, Javier A A1 - Martin, Angel Garcia AB -

The striking similarity displayed at the mechanistic level between tumorigenesis and the generation of induced pluripotent stem cells and the fact that genes and pathways relevant for embryonic development are reactivated during tumor progression highlights the link between pluripotency and cancer. Based on these observations, we tested whether it is possible to use a pluripotency-associated transcriptional reporter, whose activation is driven by the SRR2 enhancer from the Sox2 gene promoter (named S4+ reporter), to isolate cancer stem cells (CSCs) from breast cancer cell lines. The S4+ pluripotency transcriptional reporter allows the isolation of cells with enhanced tumorigenic potential and its activation was switched on and off in the cell lines studied, reflecting a plastic cellular process. Microarray analysis comparing the populations in which the reporter construct is active versus inactive showed that positive cells expressed higher mRNA levels of cytokines (IL-8, IL-6, TNF) and genes (such as ATF3, SNAI2, and KLF6) previously related with the CSC phenotype in breast cancer.

VL - 4 U1 - https://www.ncbi.nlm.nih.gov/pubmed/25414831?dopt=Abstract ER - TY - JOUR T1 - A New Overgrowth Syndrome is Due to Mutations in RNF125. JF - Human mutation Y1 - 2014 A1 - Tenorio, Jair A1 - Mansilla, Alicia A1 - Valencia, María A1 - Martínez-Glez, Víctor A1 - Romanelli, Valeria A1 - Arias, Pedro A1 - Castrejón, Nerea A1 - Poletta, Fernando A1 - Guillén-Navarro, Encarna A1 - Gordo, Gema A1 - Mansilla, Elena A1 - García-Santiago, Fé A1 - González-Casado, Isabel A1 - Vallespín, Elena A1 - Palomares, María A1 - Mori, María A A1 - Santos-Simarro, Fernando A1 - García-Miñaur, Sixto A1 - Fernández, Luis A1 - Mena, Rocío A1 - Benito-Sanz, Sara A1 - Del Pozo, Angela A1 - Silla, Juan Carlos A1 - Ibañez, Kristina A1 - López-Granados, Eduardo A1 - Martín-Trujillo, Alex A1 - Montaner, David A1 - Heath, Karen E A1 - Campos-Barros, Angel A1 - Joaquín Dopazo A1 - Nevado, Julián A1 - Monk, David A1 - Ruiz-Pérez, Víctor L A1 - Lapunzina, Pablo KW - NGS KW - prioritization KW - Rare Disease AB - Overgrowth syndromes (OGS) are a group of disorders in which all parameters of growth and physical development are above the mean for age and sex. We evaluated a series of 270 families from the Spanish Overgrowth Syndrome Registry with no known overgrowth syndrome. We identified one de novo deletion and three missense mutations in RNF125 in six patients from 4 families with overgrowth, macrocephaly, intellectual disability, mild hydrocephaly, hypoglycaemia and inflammatory diseases resembling Sjögren syndrome. RNF125 encodes an E3 ubiquitin ligase and is a novel gene of OGS. Our studies of the RNF125 pathway point to upregulation of RIG-I-IPS1-MDA5 and/or disruption of the PI3K-AKT and interferon signaling pathways as the putative final effectors. This article is protected by copyright. All rights reserved. VL - 35 UR - http://onlinelibrary.wiley.com/doi/10.1002/humu.22689/abstract ER - TY - JOUR T1 - Permanent cardiac sarcomere changes in a rabbit model of intrauterine growth restriction. JF - PLoS One Y1 - 2014 A1 - Torre, Iratxe A1 - González-Tendero, Anna A1 - García-Cañadilla, Patricia A1 - Crispi, Fátima A1 - Garcia-Garcia, Francisco A1 - Bijnens, Bart A1 - Iruretagoyena, Igor A1 - Dopazo, Joaquin A1 - Amat-Roldán, Ivan A1 - Gratacós, Eduard KW - Animals KW - biomarkers KW - Blood Pressure KW - Body Weight KW - Disease Models, Animal KW - Echocardiography KW - Female KW - Fetal Growth Retardation KW - Fetal Heart KW - Fetus KW - Gene Expression Profiling KW - Organ Size KW - Placenta KW - Pregnancy KW - Rabbits KW - Sarcomeres AB -

BACKGROUND: Intrauterine growth restriction (IUGR) induces fetal cardiac remodelling and dysfunction, which persists postnatally and may explain the link between low birth weight and increased cardiovascular mortality in adulthood. However, the cellular and molecular bases for these changes are still not well understood. We tested the hypothesis that IUGR is associated with structural and functional gene expression changes in the fetal sarcomere cytoarchitecture, which remain present in adulthood.

METHODS AND RESULTS: IUGR was induced in New Zealand pregnant rabbits by selective ligation of the utero-placental vessels. Fetal echocardiography demonstrated more globular hearts and signs of cardiac dysfunction in IUGR. Second harmonic generation microscopy (SHGM) showed shorter sarcomere length and shorter A-band and thick-thin filament interaction lengths, that were already present in utero and persisted at 70 postnatal days (adulthood). Sarcomeric M-band (GO: 0031430) functional term was over-represented in IUGR fetal hearts.

CONCLUSION: The results suggest that IUGR induces cardiac dysfunction and permanent changes on the sarcomere.

VL - 9 IS - 11 U1 - https://www.ncbi.nlm.nih.gov/pubmed/25402351?dopt=Abstract ER - TY - JOUR T1 - Mammosphere Formation in Breast Carcinoma Cell Lines Depends upon Expression of E-cadherin JF - PLoS ONE Y1 - 2013 A1 - Manuel Iglesias, Juan A1 - Beloqui, Izaskun A1 - Garcia-Garcia, Francisco A1 - Leis, Olatz A1 - Vazquez-Martin, Alejandro A1 - Eguiara, Arrate A1 - Cufi, Silvia A1 - Pavon, Andres A1 - Menendez, Javier A. A1 - Dopazo, Joaquin A1 - Martin, Angel G. AB -

Tumors are heterogeneous at the cellular level where the ability to maintain tumor growth resides in discrete cell populations. Floating sphere-forming assays are broadly used to test stem cell activity in tissues, tumors and cell lines. Spheroids are originated from a small population of cells with stem cell features able to grow in suspension culture and behaving as tumorigenic in mice. We tested the ability of eleven common breast cancer cell lines representing the major breast cancer subtypes to grow as mammospheres, measuring the ability to maintain cell viability upon serial non-adherent passage. Only MCF7, T47D, BT474, MDA-MB-436 and JIMT1 were successfully propagated as long-term mammosphere cultures, measured as the increase in the number of viable cells upon serial non-adherent passages. Other cell lines tested (SKBR3, MDA-MB-231, MDA-MB-468 and MDA-MB-435) formed cell clumps that can be disaggregated mechanically, but cell viability drops dramatically on their second passage. HCC1937 and HCC1569 cells formed typical mammospheres, although they could not be propagated as long-term mammosphere cultures. All the sphere forming lines but MDA-MB-436 express E-cadherin on their surface. Knock down of E-cadherin expression in MCF-7 cells abrogated its ability to grow as mammospheres, while re-expression of E-cadherin in SKBR3 cells allow them to form mammospheres. Therefore, the mammosphere assay is suitable to reveal stem like features in breast cancer cell lines that express E-cadherin.

PB - Public Library of Science VL - 8 UR - http://dx.doi.org/10.1371%2Fjournal.pone.0077281 ER - TY - JOUR T1 - Mammosphere formation in breast carcinoma cell lines depends upon expression of E-cadherin. JF - PLoS One Y1 - 2013 A1 - Manuel Iglesias, Juan A1 - Beloqui, Izaskun A1 - Garcia-Garcia, Francisco A1 - Leis, Olatz A1 - Vazquez-Martin, Alejandro A1 - Eguiara, Arrate A1 - Cufi, Silvia A1 - Pavon, Andres A1 - Menendez, Javier A A1 - Dopazo, Joaquin A1 - Martin, Angel G KW - Breast Neoplasms KW - Cadherins KW - Cell Line, Tumor KW - Cell Proliferation KW - Cluster Analysis KW - Female KW - gene expression KW - Gene Expression Profiling KW - Gene Expression Regulation, Neoplastic KW - Gene Knockdown Techniques KW - Humans KW - MCF-7 Cells KW - Neoplastic Stem Cells KW - Spheroids, Cellular KW - Tumor Cells, Cultured AB -

Tumors are heterogeneous at the cellular level where the ability to maintain tumor growth resides in discrete cell populations. Floating sphere-forming assays are broadly used to test stem cell activity in tissues, tumors and cell lines. Spheroids are originated from a small population of cells with stem cell features able to grow in suspension culture and behaving as tumorigenic in mice. We tested the ability of eleven common breast cancer cell lines representing the major breast cancer subtypes to grow as mammospheres, measuring the ability to maintain cell viability upon serial non-adherent passage. Only MCF7, T47D, BT474, MDA-MB-436 and JIMT1 were successfully propagated as long-term mammosphere cultures, measured as the increase in the number of viable cells upon serial non-adherent passages. Other cell lines tested (SKBR3, MDA-MB-231, MDA-MB-468 and MDA-MB-435) formed cell clumps that can be disaggregated mechanically, but cell viability drops dramatically on their second passage. HCC1937 and HCC1569 cells formed typical mammospheres, although they could not be propagated as long-term mammosphere cultures. All the sphere forming lines but MDA-MB-436 express E-cadherin on their surface. Knock down of E-cadherin expression in MCF-7 cells abrogated its ability to grow as mammospheres, while re-expression of E-cadherin in SKBR3 cells allow them to form mammospheres. Therefore, the mammosphere assay is suitable to reveal stem like features in breast cancer cell lines that express E-cadherin.

VL - 8 IS - 10 U1 - https://www.ncbi.nlm.nih.gov/pubmed/24124614?dopt=Abstract ER - TY - JOUR T1 - Differential Lipid Partitioning Between Adipocytes and Tissue Macrophages Modulates Macrophage Lipotoxicity and M2/M1 Polarization in Obese Mice. JF - Diabetes Y1 - 2011 A1 - Prieur, Xavier A1 - Mok, Crystal Y L A1 - Velagapudi, Vidya R A1 - Núñez, Vanessa A1 - Fuentes, Lucía A1 - Montaner, David A1 - Ishikawa, Ko A1 - Camacho, Alberto A1 - Barbarroja, Nuria A1 - O’Rahilly, Stephen A1 - Sethi, Jaswinder A1 - Dopazo, Joaquin A1 - Oresic, Matej A1 - Ricote, Mercedes A1 - Vidal-Puig, Antonio AB -

OBJECTIVE Obesity-associated insulin resistance is characterized by a state of chronic, low-grade inflammation that is associated with the accumulation of M1 proinflammatory macrophages in adipose tissue. Although different evidence explains the mechanisms linking the expansion of adipose tissue and adipose tissue macrophage (ATM) polarization, in the current study we investigated the concept of lipid-induced toxicity as the pathogenic link that could explain the trigger of this response. RESEARCH DESIGN AND METHODS We addressed this question using isolated ATMs and adipocytes from genetic and diet-induced murine models of obesity. Through transcriptomic and lipidomic analysis, we created a model integrating transcript and lipid species networks simultaneously occurring in adipocytes and ATMs and their reversibility by thiazolidinedione treatment. RESULTS We show that polarization of ATMs is associated with lipid accumulation and the consequent formation of foam cell-like cells in adipose tissue. Our study reveals that early stages of adipose tissue expansion are characterized by M2-polarized ATMs and that progressive lipid accumulation within ATMs heralds the M1 polarization, a macrophage phenotype associated with severe obesity and insulin resistance. Furthermore, rosiglitazone treatment, which promotes redistribution of lipids toward adipocytes and extends the M2 ATM polarization state, prevents the lipid alterations associated with M1 ATM polarization. CONCLUSIONS Our data indicate that the M1 ATM polarization in obesity might be a macrophage-specific manifestation of a more general lipotoxic pathogenic mechanism. This indicates that strategies to optimize fat deposition and repartitioning toward adipocytes might improve insulin sensitivity by preventing ATM lipotoxicity and M1 polarization.

VL - 60 ER - TY - JOUR T1 - Early peroxisome proliferator-activated receptor gamma regulated genes involved in expansion of pancreatic beta cell mass. JF - BMC Med Genomics Y1 - 2011 A1 - Vivas, Yurena A1 - Martinez-Garcia, Cristina A1 - Izquierdo, Adriana A1 - Garcia-Garcia, Francisco A1 - Callejas, Sergio A1 - Velasco, Ismael A1 - Campbell, Mark A1 - Ros, Manuel A1 - Dopazo, Ana A1 - Dopazo, Joaquin A1 - Vidal-Puig, Antonio A1 - Medina-Gomez, Gema KW - Animals KW - Cell Proliferation KW - Cell Survival KW - Cholesterol KW - Down-Regulation KW - Female KW - Gene Expression Regulation KW - Gene Knockout Techniques KW - Insulin Resistance KW - Insulin-Secreting Cells KW - Mice KW - obesity KW - Oxidation-Reduction KW - Phosphorylation KW - PPAR gamma KW - Signal Transduction KW - Transcription, Genetic KW - Transforming Growth Factor beta AB -

BACKGROUND: The progression towards type 2 diabetes depends on the allostatic response of pancreatic beta cells to synthesise and secrete enough insulin to compensate for insulin resistance. The endocrine pancreas is a plastic tissue able to expand or regress in response to the requirements imposed by physiological and pathophysiological states associated to insulin resistance such as pregnancy, obesity or ageing, but the mechanisms mediating beta cell mass expansion in these scenarios are not well defined. We have recently shown that ob/ob mice with genetic ablation of PPARγ2, a mouse model known as the POKO mouse failed to expand its beta cell mass. This phenotype contrasted with the appropriate expansion of the beta cell mass observed in their obese littermate ob/ob mice. Thus, comparison of these models islets particularly at early ages could provide some new insights on early PPARγ dependent transcriptional responses involved in the process of beta cell mass expansion

RESULTS: Here we have investigated PPARγ dependent transcriptional responses occurring during the early stages of beta cell adaptation to insulin resistance in wild type, ob/ob, PPARγ2 KO and POKO mice. We have identified genes known to regulate both the rate of proliferation and the survival signals of beta cells. Moreover we have also identified new pathways induced in ob/ob islets that remained unchanged in POKO islets, suggesting an important role for PPARγ in maintenance/activation of mechanisms essential for the continued function of the beta cell.

CONCLUSIONS: Our data suggest that the expansion of beta cell mass observed in ob/ob islets is associated with the activation of an immune response that fails to occur in POKO islets. We have also indentified other PPARγ dependent differentially regulated pathways including cholesterol biosynthesis, apoptosis through TGF-β signaling and decreased oxidative phosphorylation.

VL - 4 U1 - https://www.ncbi.nlm.nih.gov/pubmed/22208362?dopt=Abstract ER - TY - JOUR T1 - The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. JF - Nature biotechnology Y1 - 2010 A1 - Shi, Leming A1 - Campbell, Gregory A1 - Jones, Wendell D A1 - Campagne, Fabien A1 - Wen, Zhining A1 - Walker, Stephen J A1 - Su, Zhenqiang A1 - Chu, Tzu-Ming A1 - Goodsaid, Federico M A1 - Pusztai, Lajos A1 - Shaughnessy, John D A1 - Oberthuer, André A1 - Thomas, Russell S A1 - Paules, Richard S A1 - Fielden, Mark A1 - Barlogie, Bart A1 - Chen, Weijie A1 - Du, Pan A1 - Fischer, Matthias A1 - Furlanello, Cesare A1 - Gallas, Brandon D A1 - Ge, Xijin A1 - Megherbi, Dalila B A1 - Symmans, W Fraser A1 - Wang, May D A1 - Zhang, John A1 - Bitter, Hans A1 - Brors, Benedikt A1 - Bushel, Pierre R A1 - Bylesjo, Max A1 - Chen, Minjun A1 - Cheng, Jie A1 - Cheng, Jing A1 - Chou, Jeff A1 - Davison, Timothy S A1 - Delorenzi, Mauro A1 - Deng, Youping A1 - Devanarayan, Viswanath A1 - Dix, David J A1 - Dopazo, Joaquin A1 - Dorff, Kevin C A1 - Elloumi, Fathi A1 - Fan, Jianqing A1 - Fan, Shicai A1 - Fan, Xiaohui A1 - Fang, Hong A1 - Gonzaludo, Nina A1 - Hess, Kenneth R A1 - Hong, Huixiao A1 - Huan, Jun A1 - Irizarry, Rafael A A1 - Judson, Richard A1 - Juraeva, Dilafruz A1 - Lababidi, Samir A1 - Lambert, Christophe G A1 - Li, Li A1 - Li, Yanen A1 - Li, Zhen A1 - Lin, Simon M A1 - Liu, Guozhen A1 - Lobenhofer, Edward K A1 - Luo, Jun A1 - Luo, Wen A1 - McCall, Matthew N A1 - Nikolsky, Yuri A1 - Pennello, Gene A A1 - Perkins, Roger G A1 - Philip, Reena A1 - Popovici, Vlad A1 - Price, Nathan D A1 - Qian, Feng A1 - Scherer, Andreas A1 - Shi, Tieliu A1 - Shi, Weiwei A1 - Sung, Jaeyun A1 - Thierry-Mieg, Danielle A1 - Thierry-Mieg, Jean A1 - Thodima, Venkata A1 - Trygg, Johan A1 - Vishnuvajjala, Lakshmi A1 - Wang, Sue Jane A1 - Wu, Jianping A1 - Wu, Yichao A1 - Xie, Qian A1 - Yousef, Waleed A A1 - Zhang, Liang A1 - Zhang, Xuegong A1 - Zhong, Sheng A1 - Zhou, Yiming A1 - Zhu, Sheng A1 - Arasappan, Dhivya A1 - Bao, Wenjun A1 - Lucas, Anne Bergstrom A1 - Berthold, Frank A1 - Brennan, Richard J A1 - Buness, Andreas A1 - Catalano, Jennifer G A1 - Chang, Chang A1 - Chen, Rong A1 - Cheng, Yiyu A1 - Cui, Jian A1 - Czika, Wendy A1 - Demichelis, Francesca A1 - Deng, Xutao A1 - Dosymbekov, Damir A1 - Eils, Roland A1 - Feng, Yang A1 - Fostel, Jennifer A1 - Fulmer-Smentek, Stephanie A1 - Fuscoe, James C A1 - Gatto, Laurent A1 - Ge, Weigong A1 - Goldstein, Darlene R A1 - Guo, Li A1 - Halbert, Donald N A1 - Han, Jing A1 - Harris, Stephen C A1 - Hatzis, Christos A1 - Herman, Damir A1 - Huang, Jianping A1 - Jensen, Roderick V A1 - Jiang, Rui A1 - Johnson, Charles D A1 - Jurman, Giuseppe A1 - Kahlert, Yvonne A1 - Khuder, Sadik A A1 - Kohl, Matthias A1 - Li, Jianying A1 - Li, Li A1 - Li, Menglong A1 - Li, Quan-Zhen A1 - Li, Shao A1 - Li, Zhiguang A1 - Liu, Jie A1 - Liu, Ying A1 - Liu, Zhichao A1 - Meng, Lu A1 - Madera, Manuel A1 - Martinez-Murillo, Francisco A1 - Medina, Ignacio A1 - Meehan, Joseph A1 - Miclaus, Kelci A1 - Moffitt, Richard A A1 - Montaner, David A1 - Mukherjee, Piali A1 - Mulligan, George J A1 - Neville, Padraic A1 - Nikolskaya, Tatiana A1 - Ning, Baitang A1 - Page, Grier P A1 - Parker, Joel A1 - Parry, R Mitchell A1 - Peng, Xuejun A1 - Peterson, Ron L A1 - Phan, John H A1 - Quanz, Brian A1 - Ren, Yi A1 - Riccadonna, Samantha A1 - Roter, Alan H A1 - Samuelson, Frank W A1 - Schumacher, Martin M A1 - Shambaugh, Joseph D A1 - Shi, Qiang A1 - Shippy, Richard A1 - Si, Shengzhu A1 - Smalter, Aaron A1 - Sotiriou, Christos A1 - Soukup, Mat A1 - Staedtler, Frank A1 - Steiner, Guido A1 - Stokes, Todd H A1 - Sun, Qinglan A1 - Tan, Pei-Yi A1 - Tang, Rong A1 - Tezak, Zivana A1 - Thorn, Brett A1 - Tsyganova, Marina A1 - Turpaz, Yaron A1 - Vega, Silvia C A1 - Visintainer, Roberto A1 - von Frese, Juergen A1 - Wang, Charles A1 - Wang, Eric A1 - Wang, Junwei A1 - Wang, Wei A1 - Westermann, Frank A1 - Willey, James C A1 - Woods, Matthew A1 - Wu, Shujian A1 - Xiao, Nianqing A1 - Xu, Joshua A1 - Xu, Lei A1 - Yang, Lun A1 - Zeng, Xiao A1 - Zhang, Jialu A1 - Zhang, Li A1 - Zhang, Min A1 - Zhao, Chen A1 - Puri, Raj K A1 - Scherf, Uwe A1 - Tong, Weida A1 - Wolfinger, Russell D AB -

Gene expression data from microarrays are being applied to predict preclinical and clinical endpoints, but the reliability of these predictions has not been established. In the MAQC-II project, 36 independent teams analyzed six microarray data sets to generate predictive models for classifying a sample with respect to one of 13 endpoints indicative of lung or liver toxicity in rodents, or of breast cancer, multiple myeloma or neuroblastoma in humans. In total, >30,000 models were built using many combinations of analytical methods. The teams generated predictive models without knowing the biological meaning of some of the endpoints and, to mimic clinical reality, tested the models on data that had not been used for training. We found that model performance depended largely on the endpoint and team proficiency and that different approaches generated models of similar performance. The conclusions and recommendations from MAQC-II should be useful for regulatory agencies, study committees and independent investigators that evaluate methods for global gene expression analysis.

VL - 28 UR - http://www.nature.com/nbt/journal/v28/n8/full/nbt.1665.html ER - TY - JOUR T1 - Membrane transporters and carbon metabolism implicated in chloride homeostasis differentiate salt stress responses in tolerant and sensitive Citrus rootstocks JF - Funct Integr Genomics Y1 - 2009 A1 - Brumos, J. A1 - Colmenero-Flores, J. M. A1 - A. Conesa A1 - Izquierdo, P. A1 - Sanchez, G. A1 - Iglesias, D. J. A1 - Lopez-Climent, M. F. A1 - Gomez-Cadenas, A. A1 - Talon, M. AB -

Salinity tolerance in Citrus is strongly related to leaf chloride accumulation. Both chloride homeostasis and specific genetic responses to Cl(-) toxicity are issues scarcely investigated in plants. To discriminate the transcriptomic network related to Cl(-) toxicity and salinity tolerance, we have used two Cl(-) salt treatments (NaCl and KCl) to perform a comparative microarray approach on two Citrus genotypes, the salt-sensitive Carrizo citrange, a poor Cl(-) excluder, and the tolerant Cleopatra mandarin, an efficient Cl(-) excluder. The data indicated that Cl(-) toxicity, rather than Na(+) toxicity and/or the concomitant osmotic perturbation, is the primary factor involved in the molecular responses of citrus plant leaves to salinity. A number of uncharacterized membrane transporter genes, like NRT1-2, were differentially regulated in the tolerant and the sensitive genotypes, suggesting its potential implication in Cl(-) homeostasis. Analyses of enriched functional categories showed that the tolerant rootstock induced wider stress responses in gene expression while repressing central metabolic processes such as photosynthesis and carbon utilization. These features were in agreement with phenotypic changes in the patterns of photosynthesis, transpiration, and stomatal conductance and support the concept that regulation of transpiration and its associated metabolic adjustments configure an adaptive response to salinity that reduces Cl(-) accumulation in the tolerant genotype.

UR - http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19190944 N1 -

Journal article Functional & integrative genomics Funct Integr Genomics. 2009 Feb 4.

ER - TY - JOUR T1 - Parallel changes in gene expression in peripheral blood mononuclear cells and the brain after maternal separation in the mouse. JF - BMC Res Notes Y1 - 2009 A1 - Johan H van Heerden A1 - Ana Conesa A1 - Dan J Stein A1 - Montaner, David A1 - Vivienne Russell A1 - Nicola Illing VL - 2 ER - TY - JOUR T1 - Analysis of 13000 unique Citrus clusters associated with fruit quality, production and salinity tolerance JF - BMC Genomics Y1 - 2007 A1 - Terol, J. A1 - A. Conesa A1 - Colmenero, J. M. A1 - Cercos, M. A1 - Tadeo, F. A1 - Agusti, J. A1 - Alos, E. A1 - Andres, F. A1 - Soler, G. A1 - Brumos, J. A1 - Iglesias, D. J. A1 - Gotz, S. A1 - Legaz, F. A1 - Argout, X. A1 - Courtois, B. A1 - Ollitrault, P. A1 - Dossat, C. A1 - Wincker, P. A1 - Morillon, R. A1 - Talon, M. KW - Acclimatization/*genetics Amino Acid Motifs Citrus/*genetics Cluster Analysis Expressed Sequence Tags Fruit/genetics Gene Duplication *Gene Expression Regulation KW - Plant Gene Library Genes KW - Plant Genomics Molecular Sequence Data Multigene Family Phylogeny *Salts/adverse effects AB - BACKGROUND: Improvement of Citrus, the most economically important fruit crop in the world, is extremely slow and inherently costly because of the long-term nature of tree breeding and an unusual combination of reproductive characteristics. Aside from disease resistance, major commercial traits in Citrus are improved fruit quality, higher yield and tolerance to environmental stresses, especially salinity. RESULTS: A normalized full length and 9 standard cDNA libraries were generated, representing particular treatments and tissues from selected varieties (Citrus clementina and C. sinensis) and rootstocks (C. reshni, and C. sinenis x Poncirus trifoliata) differing in fruit quality, resistance to abscission, and tolerance to salinity. The goal of this work was to provide a large expressed sequence tag (EST) collection enriched with transcripts related to these well appreciated agronomical traits. Towards this end, more than 54000 ESTs derived from these libraries were analyzed and annotated. Assembly of 52626 useful sequences generated 15664 putative transcription units distributed in 7120 contigs, and 8544 singletons. BLAST annotation produced significant hits for more than 80% of the hypothetical transcription units and suggested that 647 of these might be Citrus specific unigenes. The unigene set, composed of 13000 putative different transcripts, including more than 5000 novel Citrus genes, was assigned with putative functions based on similarity, GO annotations and protein domains CONCLUSION: Comparative genomics with Arabidopsis revealed the presence of putative conserved orthologs and single copy genes in Citrus and also the occurrence of both gene duplication events and increased number of genes for specific pathways. In addition, phylogenetic analysis performed on the ammonium transporter family and glycosyl transferase family 20 suggested the existence of Citrus paralogs. Analysis of the Citrus gene space showed that the most important metabolic pathways known to affect fruit quality were represented in the unigene set. Overall, the similarity analyses indicated that the sequences of the genes belonging to these varieties and rootstocks were essentially identical, suggesting that the differential behaviour of these species cannot be attributed to major sequence divergences. This Citrus EST assembly contributes both crucial information to discover genes of agronomical interest and tools for genetic and genomic analyses, such as the development of new markers and microarrays. VL - 8 UR - http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17254327 N1 - Terol, Javier Conesa, Ana Colmenero, Jose M Cercos, Manuel Tadeo, Francisco Agusti, Javier Alos, Enriqueta Andres, Fernando Soler, Guillermo Brumos, Javier Iglesias, Domingo J Gotz, Stefan Legaz, Francisco Argout, Xavier Courtois, Brigitte Ollitrault, Patrick Dossat, Carole Wincker, Patrick Morillon, Raphael Talon, Manuel Comparative Study Research Support, Non-U.S. Gov’t England BMC genomics BMC Genomics. 2007 Jan 25;8:31. ER - TY - JOUR T1 - ModView, visualization of multiple protein sequences and structures JF - Bioinformatics Y1 - 2003 A1 - Ilyin, V. A. A1 - Pieper, U. A1 - Stuart, A. C. A1 - M. A. Marti-Renom A1 - McMahan, L. A1 - Sali, A. KW - *Database Management Systems Documentation/methods Imaging KW - Protein/*methods *User-Computer Interface KW - Three-Dimensional/methods Protein Conformation Proteins/*chemistry/genetics Sequence Alignment/*methods Sequence Analysis AB - SUMMARY: We describe ModView, a web application for visualization of multiple protein sequences and structures. ModView integrates a multiple structure viewer, a multiple sequence alignment editor, and a database querying engine. It is possible to interactively manipulate hundreds of proteins, to visualize conservative and variable residues, active and binding sites, fragments, and domains in protein families, as well as to display large macromolecular complexes such as ribosomes or viruses. As a Netscape plug-in, ModView can be included in HTML pages along with text and figures, which makes it useful for teaching and presentations. ModView is also suitable as a graphical interface to various databases because it can be controlled through JavaScript commands and called from CGI scripts. AVAILABILITY: ModView is available at http://guitar.rockefeller.edu/modview. VL - 19 UR - http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12499313 N1 - Ilyin, Valentin A Pieper, Ursula Stuart, Ashley C Marti-Renom, Marc A McMahan, Linda Sali, Andrej P50-GM62529/GM/NIGMS NIH HHS/United States Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S. England Bioinformatics (Oxford, England) Bioinformatics. 2003 Jan;19(1):165-6. ER - TY - JOUR T1 - Tools for comparative protein structure modeling and analysis JF - Nucleic Acids Res Y1 - 2003 A1 - Eswar, N. A1 - John, B. A1 - Mirkovic, N. A1 - Fiser, A. A1 - Ilyin, V. A. A1 - Pieper, U. A1 - Stuart, A. C. A1 - M. A. Marti-Renom A1 - Madhusudhan, M. S. A1 - Yerkovich, B. A1 - Sali, A. KW - Amino Acid *Software *Structural Homology KW - Internet Models KW - Molecular Protein Folding Proteins/chemistry Reproducibility of Results Sequence Alignment Sequence Homology KW - Protein Systems Integration AB - The following resources for comparative protein structure modeling and analysis are described (http://salilab.org): MODELLER, a program for comparative modeling by satisfaction of spatial restraints; MODWEB, a web server for automated comparative modeling that relies on PSI-BLAST, IMPALA and MODELLER; MODLOOP, a web server for automated loop modeling that relies on MODELLER; MOULDER, a CPU intensive protocol of MODWEB for building comparative models based on distant known structures; MODBASE, a comprehensive database of annotated comparative models for all sequences detectably related to a known structure; MODVIEW, a Netscape plugin for Linux that integrates viewing of multiple sequences and structures; and SNPWEB, a web server for structure-based prediction of the functional impact of a single amino acid substitution. VL - 31 UR - http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12824331 N1 - Eswar, Narayanan John, Bino Mirkovic, Nebojsa Fiser, Andras Ilyin, Valentin A Pieper, Ursula Stuart, Ashley C Marti-Renom, Marc A Madhusudhan, M S Yerkovich, Bozidar Sali, Andrej P50 GM62529/GM/NIGMS NIH HHS/United States R01 GM 54762/GM/NIGMS NIH HHS/United States R33 CA84699/CA/NCI NIH HHS/United States Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S. England Nucleic acids research Nucleic Acids Res. 2003 Jul 1;31(13):3375-80. ER - TY - JOUR T1 - Use of single point mutations in domain I of beta 2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies JF - J Immunol Y1 - 2002 A1 - Iverson, G. M. A1 - Reddel, S. A1 - Victoria, E. J. A1 - Cockerill, K. A. A1 - Wang, Y. X. A1 - M. A. Marti-Renom A1 - Sali, A. A1 - Marquis, D. M. A1 - Krilis, S. A. A1 - Linnik, M. D. KW - Amino Acid Substitution/genetics Antibodies KW - Antibody/genetics Binding KW - Antiphospholipid/blood/*metabolism Antibodies KW - Competitive/genetics/immunology Enzyme-Linked Immunosorbent Assay/methods Epitopes/analysis/*immunology/metabolism Glycine/genetics Glycoproteins/biosynthesis/*genetics/*immunology/isolation & purification/metabolism Humans Models KW - Molecular Peptide Fragments/genetics/immunology/isolation & purification/metabolism *Point Mutation Protein Structure KW - Monoclonal/blood/metabolism Antiphospholipid Syndrome/immunology Arginine/genetics *Binding Sites KW - Tertiary/genetics Recombinant Proteins/biosynthesis/immunology/isolation & purification/metabolism Static Electricity beta 2-Glycoprotein I AB - Autoantibodies against beta(2)-glycoprotein I (beta(2)GPI) appear to be a critical feature of the antiphospholipid syndrome (APS). As determined using domain deletion mutants, human autoantibodies bind to the first of five domains present in beta(2)GPI. In this study the fine detail of the domain I epitope has been examined using 10 selected mutants of whole beta(2)GPI containing single point mutations in the first domain. The binding to beta(2)GPI was significantly affected by a number of single point mutations in domain I, particularly by mutations in the region of aa 40-43. Molecular modeling predicted these mutations to affect the surface shape and electrostatic charge of a facet of domain I. Mutation K19E also had an effect, albeit one less severe and involving fewer patients. Similar results were obtained in two different laboratories using affinity-purified anti-beta(2)GPI in a competitive inhibition ELISA and with whole serum in a direct binding ELISA. This study confirms that anti-beta(2)GPI autoantibodies bind to domain I, and that the charged surface patch defined by residues 40-43 contributes to a dominant target epitope. VL - 169 UR - http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12471146 N1 - Iverson, G Michael Reddel, Stephen Victoria, Edward J Cockerill, Keith A Wang, Ying-Xia Marti-Renom, Marc A Sali, Andrej Marquis, David M Krilis, Steven A Linnik, Matthew D GM54762/GM/NIGMS NIH HHS/United States Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S. United States Journal of immunology (Baltimore, Md. : 1950) J Immunol. 2002 Dec 15;169(12):7097-103. ER - TY - JOUR T1 - DBAli: a database of protein structure alignments JF - Bioinformatics Y1 - 2001 A1 - M. A. Marti-Renom A1 - Ilyin, V. A. A1 - Sali, A. KW - Computational Biology *Databases KW - Protein Proteins/*chemistry/*genetics Sequence Alignment/*statistics & numerical data Software Software Design AB - SUMMARY: The DBAli database includes approximately 35000 alignments of pairs of protein structures from SCOP (Lo Conte et al., Nucleic Acids Res., 28, 257-259, 2000) and CE (Shindyalov and Bourne, Protein Eng., 11, 739-747, 1998). DBAli is linked to several resources, including Compare3D (Shindyalov and Bourne, http://www.sdsc.edu/pb/software.htm, 1999) and ModView (Ilyin and Sali, http://guitar.rockefeller.edu/ModView/, 2001) for visualizing sequence alignments and structure superpositions. A flexible search of DBAli by protein sequence and structure properties allows construction of subsets of alignments suitable for a number of applications, such as benchmarking of sequence-sequence and sequence-structure alignment methods under a variety of conditions. AVAILABILITY: http://guitar.rockefeller.edu/DBAli/ VL - 17 UR - http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11524379 N1 - Marti-Renom, M A Ilyin, V A Sali, A Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S. England Bioinformatics (Oxford, England) Bioinformatics. 2001 Aug;17(8):746-7. ER -